45
Participants
Start Date
September 1, 2025
Primary Completion Date
August 31, 2026
Study Completion Date
February 28, 2027
Simultaneous cessation intervention
This simultaneous cessation intervention group will target CCs and ECs at the same time. Participants in this group will receive a multi-component cessation intervention, including behavior counseling, biomarker feedback via monitoring changes in levels of exposure to nicotine (urine cotinine) and CC smoke (breath carbon monoxide), and contingent financial incentives for biochemically verified abstinence.
Stepwise cessation intervention
This stepwise cessation intervention group will first target CCs and then target ECs after quitting CCs. Participants in this group will receive a multi-component cessation intervention, including behavior counseling, biomarker feedback via monitoring changes in levels of exposure to nicotine (urine cotinine) and CC smoke (breath carbon monoxide), and contingent financial incentives for biochemically verified abstinence.
Behavior counseling only
Participants assigned to the control group will receive behavior counseling only. They will complete the same number of study visits as their counterparts in the intervention groups.
State University of New York at Buffalo, Buffalo
National Center for Advancing Translational Sciences (NCATS)
NIH
State University of New York at Buffalo
OTHER